Abstract C30H32C112N2O8S4, monoclinic, P\2\ln\ (no. 14), a = 9.7712(9) A, b = 10.734(1) A, c = 15.457(2) A, β = 98.136(2)°, V= 1604.9 A 3 ,Z= 2, Rg^F) = 0.061, wRreffF 2 ) = 0.191, 7= 298 K.
Source of material The complex was synthesized by layer-method using three-layer solutions in a slender tube. The upper layer solution was 5 ml of CH3OH containing 0.06 Μ l,4-diazabicyclo[2.2.2]octane. The bottom layer solution was 5 ml of DMF solution containing 0.03 Μ Cu(N03>2 · 3H2O and 0.06 Μ 2-thiopheneacetic acid. The intermediate layer was 5 ml of CH3OH/DMF (ν/ν 1:1) mixed solvent. After standing for two weeks, green block-shaped crystals were obtained and collected by suction filtration.
Experimental details
The carbon-bonded Η atoms were generated geometrically (d(Caromatic-H) = 0.93 A, d(Csp3-H) = 0.97 A, l/iso = 1.2 i/eq). These were included in the refinement in the riding model approximation. The l,4-diazabicyclo[2.2.2]octane ligand is in disorder created by the inversion center and considered over two sites. The small U values of C4 may be caused by a little part of disordered sulfur atoms which occupy the C4 position.
Discussion
Thiophene derivatives show biological activities and have been used in pharmaceutical and clinical purpose [1] . Recently, thiophenecarboxylate complexes have received increasing attention, but only seven 2-thiopheneacetate (tpa) complexes have been structurally characterized [1] [2] [3] [4] 
